Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

959 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Mutation and cell state compatibility is required and targetable in Ph + acute lymphoblastic leukemia minimal residual disease.
Winter PS, Ramseier ML, Navia AW, Saksena S, Strouf H, Senhaji N, DenAdel A, Mirza M, An HH, Bilal L, Dennis P, Leahy CS, Shigemori K, Galves-Reyes J, Zhang Y, Powers F, Mulugeta N, Gupta AJ, Calistri N, Van Scoyk A, Jones K, Liu H, Stevenson KE, Ren S, Luskin MR, Couturier CP, Amini AP, Raghavan S, Kimmerling RJ, Stevens MM, Crawford L, Weinstock DM, Manalis SR, Shalek AK, Murakami MA. Winter PS, et al. Among authors: amini ap. bioRxiv [Preprint]. 2024 Jun 10:2024.06.06.597767. doi: 10.1101/2024.06.06.597767. bioRxiv. 2024. PMID: 38915726 Free PMC article. Preprint.
Correction to: Photobiomodulation preconditioned diabetic adipose derived stem cells with additional photobiomodulation: an additive approach for enhanced wound healing in diabetic rats with a delayed healing wound.
Vatandoust D, Ahmadi H, Amini A, Mostafavinia A, Fathabady FF, Moradi A, Fridoni M, Hamblin MR, Ebrahimpour-Malekshah R, Chien S, Bayat M. Vatandoust D, et al. Among authors: amini a. Lasers Med Sci. 2024 Jun 24;39(1):163. doi: 10.1007/s10103-024-04036-9. Lasers Med Sci. 2024. PMID: 38910226 No abstract available.
Spatial iTME analysis of KRAS mutant NSCLC and immunotherapy outcome.
Zhao D, Li H, Mambetsariev I, Mirzapoiazova T, Chen C, Fricke J, Wheeler D, Arvanitis L, Pillai R, Afkhami M, Chen BT, Sattler M, Erhunmwunsee L, Massarelli E, Kulkarni P, Amini A, Armstrong B, Salgia R. Zhao D, et al. Among authors: amini a. NPJ Precis Oncol. 2024 Jun 19;8(1):135. doi: 10.1038/s41698-024-00626-6. NPJ Precis Oncol. 2024. PMID: 38898200 Free PMC article.
959 results